PHARMACEUTICAL SYSTEM STRENGTHENING IN UGANDA: IMPLEMENTING A HOLISTIC, EVIDENCE-INFORMED, LONG-TERM STRATEGY


Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation

here Snakebite remains a neglected medical problem of the developing world with up to 125,000 deaths each year despite more than a century of calls to improve snakebite prevention and care.An estimated 75% of fatalities from snakebite occur outside the hospital setting.Because phospholipase A2 (PLA2) activity is an important component of venom toxi

read more

Vascular inflammatory cells in hypertension

Hypertension is a common disorder with uncertain etiology.In the last several years, it has become evident that components of both the innate and adaptive immune system play an essential role in hypertension.Macrophages and T cells accumulate in the perivascular fat, the heart and the kidney of hypertensive patients and in animals with experimental

read more